Dendritic cells and CCAAT/enhancer binding protein-delta (CEBP?) in neuroinflammation and autoimmunity

该项目旨在通过寻找能够自然阻止多发性硬化症等疾病中枢神经系统炎症的细胞和化学物质来开发新的治疗方法。该项目还旨在通过将这些细胞和化学物质输送到炎症发生的地方来测试新的治疗方法。这种有针对性的递送应该意味着更少的副作用，因为身体的其他部分不会暴露在治疗中。希望这将减少这些疾病对社区的影响，并减少对患者的副作用。

This projects aims to develop new treatments by finding the cells and chemicals that naturally stop inflammation in the central nervous system in diseases like MS. It also aims to test new treatments by delivering them to where this inflammation takes place. This targeted delivery should mean fewer side effects because the rest of the body is not exposed to the treatment. Hopefully this will reduce the impact of these diseases on the community, and reduce side effects for the patient.